cas 2306390-08-7|| where to buy 2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetic acid

Nom du produit:2-[4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-(4-methoxy-2-propan-2-yloxyphenyl)-4,5-dihydroimidazole-1-carbonyl]-2-oxopiperazin-1-yl]acetic acid

IUPAC Name:2-{4-[(4R,5S)-4,5-bis(4-chlorophenyl)-2-[4-methoxy-2-(propan-2-yloxy)phenyl]-4,5-dihydro-1H-imidazole-1-carbonyl]-2-oxopiperazin-1-yl}acetic acid

: CAS：2306390-08-7; Formule moléculaire：C32H32Cl2N4O6; Pureté：95%+

: Numéro de catalogue：CM340805; Poids moléculaire：639.53

Unité d'emballage	Stock disponible	Prix($)
CM340805-50mg	in stock	ǆşȤ
CM340805-100mg	in stock	ƚǆǆ
CM340805-250mg	in stock	ǠşȤǠ
CM340805-1g	in stock	œŸƐƚ

Demande: sales@chemenu.com

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2306390-08-7 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

Détails du produit

: N° CAS:2306390-08-7; Formule moléculaire:C32H32Cl2N4O6; Point de fusion:-; Code SMILES:O=C(O)CN1C(CN(C(N2[C@@H](C3=CC=C(Cl)C=C3)[C@@H](C4=CC=C(Cl)C=C4)N=C2C5=CC=C(OC)C=C5OC(C)C)=O)CC1)=O; Densité:

: Numéro de catalogue:CM340805; Poids moléculaire:639.53; Point d'ébullition:; N° Mdl:; Stockage:

Category Infos

: PROTAC-E3 Ligase Ligands; Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.; PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules; Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules; PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.

Formulaire de demande

Détails du produit

Category Infos

Related Products